Edition:
United States

MacroGenics Inc (MGNX.OQ)

MGNX.OQ on NASDAQ Stock Exchange Global Select Market

21.61USD
28 Apr 2017
Change (% chg)

$-0.14 (-0.64%)
Prev Close
$21.75
Open
$21.76
Day's High
$21.76
Day's Low
$21.38
Volume
52,932
Avg. Vol
96,986
52-wk High
$33.30
52-wk Low
$16.50

MGNX.OQ

Chart for MGNX.OQ

About

MacroGenics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing monoclonal antibody-based therapeutics for the treatment of cancer, as well as various autoimmune disorders and infectious diseases. The Company develops therapeutic product candidates using its antibody-based technology... (more)

Overall

Beta: 2.89
Market Cap(Mil.): $755.87
Shares Outstanding(Mil.): 34.98
Dividend: --
Yield (%): --

Financials

  MGNX.OQ Industry Sector
P/E (TTM): -- 58.40 30.08
EPS (TTM): -1.73 -- --
ROI: -18.91 -0.42 13.25
ROE: -20.11 5.87 14.41

BRIEF-Macrogenics announces registered direct offering of common stock

* Macrogenics announces registered direct offering of common stock

Apr 27 2017

BRIEF-Macrogenics provides announces 2016 financial results

* Macrogenics provides update on corporate progress and 2016 financial results

Feb 28 2017

BRIEF-Macrogenics makes board changes

* Macrogenics Inc- on Jan 25, co announced an increase to number of members of company's board of directors from six to eight members- sec filing Source text for Eikon: Further company coverage:

Jan 26 2017

BRIEF-Macrogenics files for potential mixed shelf offering

* Files for potential mixed shelf offering; size not disclosed - SEC filing Source text: [http://bit.ly/2eBbLcf] Further company coverage:

Nov 02 2016

BRIEF-Macrogenics Qtrly loss per share $0.97

* Q3 earnings per share view $-0.80, revenue view $12.5 million -- Thomson Reuters I/B/E/S

Nov 02 2016

More From Around the Web

Competitors

  Price Chg
Roche Holding Ltd. (ROG.S) CHF260.30 0.00
Roche Holding Ltd. (RO.S) CHF260.50 -1.00
Amgen, Inc. (AMGN.OQ) $163.32 +0.60
Xencor Inc (XNCR.OQ) $25.67 -0.10

Earnings vs. Estimates